#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Peering into the Brain to Predict Behavior: Peer-Reported, but not Self-Reported, Conscientiousness Links Threat-Related Amygdala Activity to Future Problem Drinking Personality traits such as conscientiousness as self-reported by individuals can help predict a range of outcomes, from job performance to longevity.
1-1	0-7	Peering	_
1-2	8-12	into	_
1-3	13-16	the	_
1-4	17-22	Brain	_
1-5	23-25	to	_
1-6	26-33	Predict	_
1-7	34-42	Behavior	_
1-8	43-44	:	_
1-9	45-58	Peer-Reported	_
1-10	59-60	,	_
1-11	61-64	but	_
1-12	65-68	not	_
1-13	69-82	Self-Reported	_
1-14	83-84	,	_
1-15	85-102	Conscientiousness	_
1-16	103-108	Links	_
1-17	109-123	Threat-Related	_
1-18	124-132	Amygdala	_
1-19	133-141	Activity	_
1-20	142-144	to	_
1-21	145-151	Future	_
1-22	152-159	Problem	_
1-23	160-168	Drinking	_
1-24	169-180	Personality	_
1-25	181-187	traits	_
1-26	188-192	such	_
1-27	193-195	as	_
1-28	196-213	conscientiousness	_
1-29	214-216	as	_
1-30	217-230	self-reported	_
1-31	231-233	by	_
1-32	234-245	individuals	_
1-33	246-249	can	_
1-34	250-254	help	_
1-35	255-262	predict	_
1-36	263-264	a	_
1-37	265-270	range	_
1-38	271-273	of	_
1-39	274-282	outcomes	_
1-40	283-284	,	_
1-41	285-289	from	_
1-42	290-293	job	_
1-43	294-305	performance	_
1-44	306-308	to	_
1-45	309-318	longevity	_
1-46	319-320	.	_

Text=Asking others to rate the personality of their acquaintances often provides even better predictive power than using self-report.
2-1	321-327	Asking	_
2-2	328-334	others	_
2-3	335-337	to	_
2-4	338-342	rate	_
2-5	343-346	the	_
2-6	347-358	personality	_
2-7	359-361	of	_
2-8	362-367	their	_
2-9	368-381	acquaintances	_
2-10	382-387	often	_
2-11	388-396	provides	_
2-12	397-401	even	_
2-13	402-408	better	_
2-14	409-419	predictive	_
2-15	420-425	power	_
2-16	426-430	than	_
2-17	431-436	using	_
2-18	437-448	self-report	_
2-19	449-450	.	_

Text=Here, we examine whether peer-reported personality can provide a better link between brain function, namely threat-related amygdala activity, and future health-related behavior, namely problem drinking, than self-reported personality.
3-1	451-455	Here	_
3-2	456-457	,	_
3-3	458-460	we	_
3-4	461-468	examine	_
3-5	469-476	whether	_
3-6	477-490	peer-reported	_
3-7	491-502	personality	_
3-8	503-506	can	_
3-9	507-514	provide	_
3-10	515-516	a	_
3-11	517-523	better	_
3-12	524-528	link	_
3-13	529-536	between	_
3-14	537-542	brain	_
3-15	543-551	function	_
3-16	552-553	,	_
3-17	554-560	namely	_
3-18	561-575	threat-related	_
3-19	576-584	amygdala	_
3-20	585-593	activity	_
3-21	594-595	,	_
3-22	596-599	and	_
3-23	600-606	future	_
3-24	607-621	health-related	_
3-25	622-630	behavior	_
3-26	631-632	,	_
3-27	633-639	namely	_
3-28	640-647	problem	_
3-29	648-656	drinking	_
3-30	657-658	,	_
3-31	659-663	than	_
3-32	664-677	self-reported	_
3-33	678-689	personality	_
3-34	690-691	.	_

Text=Using data from a sample of 377 young adult university students who were rated on five personality traits by peers, we find that higher threat-related amygdala activity to fearful facial expressions is associated with higher peer-reported, but not self-reported, conscientiousness.
4-1	692-697	Using	_
4-2	698-702	data	_
4-3	703-707	from	_
4-4	708-709	a	_
4-5	710-716	sample	_
4-6	717-719	of	_
4-7	720-723	377	_
4-8	724-729	young	_
4-9	730-735	adult	_
4-10	736-746	university	_
4-11	747-755	students	_
4-12	756-759	who	_
4-13	760-764	were	_
4-14	765-770	rated	_
4-15	771-773	on	_
4-16	774-778	five	_
4-17	779-790	personality	_
4-18	791-797	traits	_
4-19	798-800	by	_
4-20	801-806	peers	_
4-21	807-808	,	_
4-22	809-811	we	_
4-23	812-816	find	_
4-24	817-821	that	_
4-25	822-828	higher	_
4-26	829-843	threat-related	_
4-27	844-852	amygdala	_
4-28	853-861	activity	_
4-29	862-864	to	_
4-30	865-872	fearful	_
4-31	873-879	facial	_
4-32	880-891	expressions	_
4-33	892-894	is	_
4-34	895-905	associated	_
4-35	906-910	with	_
4-36	911-917	higher	_
4-37	918-931	peer-reported	_
4-38	932-933	,	_
4-39	934-937	but	_
4-40	938-941	not	_
4-41	942-955	self-reported	_
4-42	956-957	,	_
4-43	958-975	conscientiousness	_
4-44	976-977	.	_

Text=Moreover, higher peer-reported, but not self-reported, conscientiousness predicts lower future problem drinking more than one year later, an effect specific to men.
5-1	978-986	Moreover	_
5-2	987-988	,	_
5-3	989-995	higher	_
5-4	996-1009	peer-reported	_
5-5	1010-1011	,	_
5-6	1012-1015	but	_
5-7	1016-1019	not	_
5-8	1020-1033	self-reported	_
5-9	1034-1035	,	_
5-10	1036-1053	conscientiousness	_
5-11	1054-1062	predicts	_
5-12	1063-1068	lower	_
5-13	1069-1075	future	_
5-14	1076-1083	problem	_
5-15	1084-1092	drinking	_
5-16	1093-1097	more	_
5-17	1098-1102	than	_
5-18	1103-1106	one	_
5-19	1107-1111	year	_
5-20	1112-1117	later	_
5-21	1118-1119	,	_
5-22	1120-1122	an	_
5-23	1123-1129	effect	_
5-24	1130-1138	specific	_
5-25	1139-1141	to	_
5-26	1142-1145	men	_
5-27	1146-1147	.	_

Text=Remarkably, relatively higher amygdala activity has an indirect effect on future drinking behavior in men, linked by peer-reported conscientiousness to lower future problem drinking.
6-1	1148-1158	Remarkably	_
6-2	1159-1160	,	_
6-3	1161-1171	relatively	_
6-4	1172-1178	higher	_
6-5	1179-1187	amygdala	_
6-6	1188-1196	activity	_
6-7	1197-1200	has	_
6-8	1201-1203	an	_
6-9	1204-1212	indirect	_
6-10	1213-1219	effect	_
6-11	1220-1222	on	_
6-12	1223-1229	future	_
6-13	1230-1238	drinking	_
6-14	1239-1247	behavior	_
6-15	1248-1250	in	_
6-16	1251-1254	men	_
6-17	1255-1256	,	_
6-18	1257-1263	linked	_
6-19	1264-1266	by	_
6-20	1267-1280	peer-reported	_
6-21	1281-1298	conscientiousness	_
6-22	1299-1301	to	_
6-23	1302-1307	lower	_
6-24	1308-1314	future	_
6-25	1315-1322	problem	_
6-26	1323-1331	drinking	_
6-27	1332-1333	.	_

Text=Our results provide initial evidence that the perceived conscientiousness of an individual by their peers uniquely reflects variability in a core neural mechanism supporting threat responsiveness.
7-1	1334-1337	Our	_
7-2	1338-1345	results	_
7-3	1346-1353	provide	_
7-4	1354-1361	initial	_
7-5	1362-1370	evidence	_
7-6	1371-1375	that	_
7-7	1376-1379	the	_
7-8	1380-1389	perceived	_
7-9	1390-1407	conscientiousness	_
7-10	1408-1410	of	_
7-11	1411-1413	an	_
7-12	1414-1424	individual	_
7-13	1425-1427	by	_
7-14	1428-1433	their	_
7-15	1434-1439	peers	_
7-16	1440-1448	uniquely	_
7-17	1449-1457	reflects	_
7-18	1458-1469	variability	_
7-19	1470-1472	in	_
7-20	1473-1474	a	_
7-21	1475-1479	core	_
7-22	1480-1486	neural	_
7-23	1487-1496	mechanism	_
7-24	1497-1507	supporting	_
7-25	1508-1514	threat	_
7-26	1515-1529	responsiveness	_
7-27	1530-1531	.	_

Text=These novel patterns further suggest that incorporating peer-reported measures of personality into individual differences research can reveal novel predictive pathways of risk and protection for problem behaviors.
8-1	1532-1537	These	_
8-2	1538-1543	novel	_
8-3	1544-1552	patterns	_
8-4	1553-1560	further	_
8-5	1561-1568	suggest	_
8-6	1569-1573	that	_
8-7	1574-1587	incorporating	_
8-8	1588-1601	peer-reported	_
8-9	1602-1610	measures	_
8-10	1611-1613	of	_
8-11	1614-1625	personality	_
8-12	1626-1630	into	_
8-13	1631-1641	individual	_
8-14	1642-1653	differences	_
8-15	1654-1662	research	_
8-16	1663-1666	can	_
8-17	1667-1673	reveal	_
8-18	1674-1679	novel	_
8-19	1680-1690	predictive	_
8-20	1691-1699	pathways	_
8-21	1700-1702	of	_
8-22	1703-1707	risk	_
8-23	1708-1711	and	_
8-24	1712-1722	protection	_
8-25	1723-1726	for	_
8-26	1727-1734	problem	_
8-27	1735-1744	behaviors	_
8-28	1745-1746	.	_

Text=2.
9-1	1747-1748	2	_
9-2	1749-1750	.	_

Text=Materials and Methods 2.1 Participants Of the 1,202 participants recruited as part of the ongoing Duke Neurogenetics Study (DNS) as of June, 2015, participants for the present study included 418 young adult university students who had informant data from at least one peer.
10-1	1751-1760	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-2	1761-1764	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-3	1765-1772	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-4	1773-1776	2.1	_
10-5	1777-1789	Participants	_
10-6	1790-1792	Of	_
10-7	1793-1796	the	_
10-8	1797-1802	1,202	_
10-9	1803-1815	participants	_
10-10	1816-1825	recruited	_
10-11	1826-1828	as	_
10-12	1829-1833	part	_
10-13	1834-1836	of	_
10-14	1837-1840	the	_
10-15	1841-1848	ongoing	_
10-16	1849-1853	Duke	_
10-17	1854-1867	Neurogenetics	_
10-18	1868-1873	Study	_
10-19	1874-1875	(	_
10-20	1876-1879	DNS	_
10-21	1880-1881	)	_
10-22	1882-1884	as	_
10-23	1885-1887	of	_
10-24	1888-1892	June	_
10-25	1893-1894	,	_
10-26	1895-1899	2015	_
10-27	1900-1901	,	_
10-28	1902-1914	participants	_
10-29	1915-1918	for	_
10-30	1919-1922	the	_
10-31	1923-1930	present	_
10-32	1931-1936	study	_
10-33	1937-1945	included	_
10-34	1946-1949	418	_
10-35	1950-1955	young	_
10-36	1956-1961	adult	_
10-37	1962-1972	university	_
10-38	1973-1981	students	_
10-39	1982-1985	who	_
10-40	1986-1989	had	_
10-41	1990-1999	informant	_
10-42	2000-2004	data	_
10-43	2005-2009	from	_
10-44	2010-2012	at	_
10-45	2013-2018	least	_
10-46	2019-2022	one	_
10-47	2023-2027	peer	_
10-48	2028-2029	.	_

Text=All procedures were approved by the Duke University Medical Center and participants provided informed consent before study initiation.
11-1	2030-2033	All	_
11-2	2034-2044	procedures	_
11-3	2045-2049	were	_
11-4	2050-2058	approved	_
11-5	2059-2061	by	_
11-6	2062-2065	the	_
11-7	2066-2070	Duke	_
11-8	2071-2081	University	_
11-9	2082-2089	Medical	_
11-10	2090-2096	Center	_
11-11	2097-2100	and	_
11-12	2101-2113	participants	_
11-13	2114-2122	provided	_
11-14	2123-2131	informed	_
11-15	2132-2139	consent	_
11-16	2140-2146	before	_
11-17	2147-2152	study	_
11-18	2153-2163	initiation	_
11-19	2164-2165	.	_

Text=Participants were college-aged (M=19.8 years, SD=1.3, range: 18 to 22) and 61% were female.
12-1	2166-2178	Participants	_
12-2	2179-2183	were	_
12-3	2184-2196	college-aged	_
12-4	2197-2198	(	_
12-5	2199-2205	M=19.8	_
12-6	2206-2211	years	_
12-7	2212-2213	,	_
12-8	2214-2220	SD=1.3	_
12-9	2221-2222	,	_
12-10	2223-2228	range	_
12-11	2229-2230	:	_
12-12	2231-2233	18	_
12-13	2234-2236	to	_
12-14	2237-2239	22	_
12-15	2240-2241	)	_
12-16	2242-2245	and	_
12-17	2246-2248	61	_
12-18	2249-2250	%	_
12-19	2251-2255	were	_
12-20	2256-2262	female	_
12-21	2263-2264	.	_

Text=Within the current sample, 48% were Caucasian, 32% were Asian, 9% were African American, 7% were bi- or multi-racial, .5% were Native American, and 3.5% self-reported as other.
13-1	2265-2271	Within	_
13-2	2272-2275	the	_
13-3	2276-2283	current	_
13-4	2284-2290	sample	_
13-5	2291-2292	,	_
13-6	2293-2295	48	_
13-7	2296-2297	%	_
13-8	2298-2302	were	_
13-9	2303-2312	Caucasian	_
13-10	2313-2314	,	_
13-11	2315-2317	32	_
13-12	2318-2319	%	_
13-13	2320-2324	were	_
13-14	2325-2330	Asian	_
13-15	2331-2332	,	_
13-16	2333-2334	9	_
13-17	2335-2336	%	_
13-18	2337-2341	were	_
13-19	2342-2349	African	_
13-20	2350-2358	American	_
13-21	2359-2360	,	_
13-22	2361-2362	7	_
13-23	2363-2364	%	_
13-24	2365-2369	were	_
13-25	2370-2373	bi-	_
13-26	2374-2376	or	_
13-27	2377-2389	multi-racial	_
13-28	2390-2391	,	_
13-29	2392-2394	.5	_
13-30	2395-2396	%	_
13-31	2397-2401	were	_
13-32	2402-2408	Native	_
13-33	2409-2417	American	_
13-34	2418-2419	,	_
13-35	2420-2423	and	_
13-36	2424-2427	3.5	_
13-37	2428-2429	%	_
13-38	2430-2443	self-reported	_
13-39	2444-2446	as	_
13-40	2447-2452	other	_
13-41	2453-2454	.	_

Text=Diagnosis of any past or current DSM-IV Axis I disorder or select Axis II disorders (antisocial personality disorder and borderline personality disorder), assessed with the electronic Mini International Neuropsychiatric Interview and Structured Clinical Interview for the DSM-IV subtests was not an exclusion.
14-1	2455-2464	Diagnosis	_
14-2	2465-2467	of	_
14-3	2468-2471	any	_
14-4	2472-2476	past	_
14-5	2477-2479	or	_
14-6	2480-2487	current	_
14-7	2488-2494	DSM-IV	_
14-8	2495-2499	Axis	_
14-9	2500-2501	I	_
14-10	2502-2510	disorder	_
14-11	2511-2513	or	_
14-12	2514-2520	select	_
14-13	2521-2525	Axis	_
14-14	2526-2528	II	_
14-15	2529-2538	disorders	_
14-16	2539-2540	(	_
14-17	2541-2551	antisocial	_
14-18	2552-2563	personality	_
14-19	2564-2572	disorder	_
14-20	2573-2576	and	_
14-21	2577-2587	borderline	_
14-22	2588-2599	personality	_
14-23	2600-2608	disorder	_
14-24	2609-2610	)	_
14-25	2611-2612	,	_
14-26	2613-2621	assessed	_
14-27	2622-2626	with	_
14-28	2627-2630	the	_
14-29	2631-2641	electronic	_
14-30	2642-2646	Mini	_
14-31	2647-2660	International	_
14-32	2661-2677	Neuropsychiatric	_
14-33	2678-2687	Interview	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies
14-34	2688-2691	and	_
14-35	2692-2702	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
14-36	2703-2711	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
14-37	2712-2721	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
14-38	2722-2725	for	_
14-39	2726-2729	the	_
14-40	2730-2736	DSM-IV	_
14-41	2737-2745	subtests	_
14-42	2746-2749	was	_
14-43	2750-2753	not	_
14-44	2754-2756	an	_
14-45	2757-2766	exclusion	_
14-46	2767-2768	.	_

Text=Within the current sample, 67 participants (16%) had at least one past or current psychiatric diagnosis.
15-1	2769-2775	Within	_
15-2	2776-2779	the	_
15-3	2780-2787	current	_
15-4	2788-2794	sample	_
15-5	2795-2796	,	_
15-6	2797-2799	67	_
15-7	2800-2812	participants	_
15-8	2813-2814	(	_
15-9	2815-2817	16	_
15-10	2818-2819	%	_
15-11	2820-2821	)	_
15-12	2822-2825	had	_
15-13	2826-2828	at	_
15-14	2829-2834	least	_
15-15	2835-2838	one	_
15-16	2839-2843	past	_
15-17	2844-2846	or	_
15-18	2847-2854	current	_
15-19	2855-2866	psychiatric	_
15-20	2867-2876	diagnosis	_
15-21	2877-2878	.	_

Text=The most frequent past and current diagnoses were as follows: 35 with alcohol use disorder, 11 with a non-alcoholic substance use disorder, and 18 with major depressive disorder (these include comorbid diagnoses).
16-1	2879-2882	The	_
16-2	2883-2887	most	_
16-3	2888-2896	frequent	_
16-4	2897-2901	past	_
16-5	2902-2905	and	_
16-6	2906-2913	current	_
16-7	2914-2923	diagnoses	_
16-8	2924-2928	were	_
16-9	2929-2931	as	_
16-10	2932-2939	follows	_
16-11	2940-2941	:	_
16-12	2942-2944	35	_
16-13	2945-2949	with	_
16-14	2950-2957	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
16-15	2958-2961	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
16-16	2962-2970	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
16-17	2971-2972	,	_
16-18	2973-2975	11	_
16-19	2976-2980	with	_
16-20	2981-2982	a	_
16-21	2983-2996	non-alcoholic	_
16-22	2997-3006	substance	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder
16-23	3007-3010	use	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder
16-24	3011-3019	disorder	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder
16-25	3020-3021	,	_
16-26	3022-3025	and	_
16-27	3026-3028	18	_
16-28	3029-3033	with	_
16-29	3034-3039	major	_
16-30	3040-3050	depressive	_
16-31	3051-3059	disorder	_
16-32	3060-3061	(	_
16-33	3062-3067	these	_
16-34	3068-3075	include	_
16-35	3076-3084	comorbid	_
16-36	3085-3094	diagnoses	_
16-37	3095-3096	)	_
16-38	3097-3098	.	_

Text=As part of the DNS protocol, participants were asked to nominate 3 individuals that knew them well to complete informant reports.
17-1	3099-3101	As	_
17-2	3102-3106	part	_
17-3	3107-3109	of	_
17-4	3110-3113	the	_
17-5	3114-3117	DNS	http://maven.renci.org/NeuroBridge/neurobridge#Thing
17-6	3118-3126	protocol	_
17-7	3127-3128	,	_
17-8	3129-3141	participants	_
17-9	3142-3146	were	_
17-10	3147-3152	asked	_
17-11	3153-3155	to	_
17-12	3156-3164	nominate	_
17-13	3165-3166	3	_
17-14	3167-3178	individuals	_
17-15	3179-3183	that	_
17-16	3184-3188	knew	_
17-17	3189-3193	them	_
17-18	3194-3198	well	_
17-19	3199-3201	to	_
17-20	3202-3210	complete	_
17-21	3211-3220	informant	_
17-22	3221-3228	reports	_
17-23	3229-3230	.	_

Text=Nominated individuals were contacted by e-mail and sent a link to complete the informant questionnaire online.
18-1	3231-3240	Nominated	_
18-2	3241-3252	individuals	_
18-3	3253-3257	were	_
18-4	3258-3267	contacted	_
18-5	3268-3270	by	_
18-6	3271-3277	e-mail	_
18-7	3278-3281	and	_
18-8	3282-3286	sent	_
18-9	3287-3288	a	_
18-10	3289-3293	link	_
18-11	3294-3296	to	_
18-12	3297-3305	complete	_
18-13	3306-3309	the	_
18-14	3310-3319	informant	_
18-15	3320-3333	questionnaire	_
18-16	3334-3340	online	_
18-17	3341-3342	.	_

Text=As part of the questionnaire, informants self-selected belonging to one of the following categories: parent, sibling, other relative, close friend, spouse/partner, employer, or other.
19-1	3343-3345	As	_
19-2	3346-3350	part	_
19-3	3351-3353	of	_
19-4	3354-3357	the	_
19-5	3358-3371	questionnaire	_
19-6	3372-3373	,	_
19-7	3374-3384	informants	_
19-8	3385-3398	self-selected	_
19-9	3399-3408	belonging	_
19-10	3409-3411	to	_
19-11	3412-3415	one	_
19-12	3416-3418	of	_
19-13	3419-3422	the	_
19-14	3423-3432	following	_
19-15	3433-3443	categories	_
19-16	3444-3445	:	_
19-17	3446-3452	parent	_
19-18	3453-3454	,	_
19-19	3455-3462	sibling	_
19-20	3463-3464	,	_
19-21	3465-3470	other	_
19-22	3471-3479	relative	_
19-23	3480-3481	,	_
19-24	3482-3487	close	_
19-25	3488-3494	friend	_
19-26	3495-3496	,	_
19-27	3497-3511	spouse/partner	_
19-28	3512-3513	,	_
19-29	3514-3522	employer	_
19-30	3523-3524	,	_
19-31	3525-3527	or	_
19-32	3528-3533	other	_
19-33	3534-3535	.	_

Text=For the purposes of the present study, we defined a peer as any informant who self-identified as a close friend and who was within 4 years of age to the participant.
20-1	3536-3539	For	_
20-2	3540-3543	the	_
20-3	3544-3552	purposes	_
20-4	3553-3555	of	_
20-5	3556-3559	the	_
20-6	3560-3567	present	_
20-7	3568-3573	study	_
20-8	3574-3575	,	_
20-9	3576-3578	we	_
20-10	3579-3586	defined	_
20-11	3587-3588	a	_
20-12	3589-3593	peer	_
20-13	3594-3596	as	_
20-14	3597-3600	any	_
20-15	3601-3610	informant	_
20-16	3611-3614	who	_
20-17	3615-3630	self-identified	_
20-18	3631-3633	as	_
20-19	3634-3635	a	_
20-20	3636-3641	close	_
20-21	3642-3648	friend	_
20-22	3649-3652	and	_
20-23	3653-3656	who	_
20-24	3657-3660	was	_
20-25	3661-3667	within	_
20-26	3668-3669	4	_
20-27	3670-3675	years	_
20-28	3676-3678	of	_
20-29	3679-3682	age	_
20-30	3683-3685	to	_
20-31	3686-3689	the	_
20-32	3690-3701	participant	_
20-33	3702-3703	.	_

Text=Peer informants were generally college-aged (M=19.9, SD=1.4, range: 16 to 25 years), 66% were female, and, on a scale from 1 (Not very well) to 3 (Very well), reported knowing the participants very well (M=2.82, SD=0.4).
21-1	3704-3708	Peer	_
21-2	3709-3719	informants	_
21-3	3720-3724	were	_
21-4	3725-3734	generally	_
21-5	3735-3747	college-aged	_
21-6	3748-3749	(	_
21-7	3750-3756	M=19.9	_
21-8	3757-3758	,	_
21-9	3759-3765	SD=1.4	_
21-10	3766-3767	,	_
21-11	3768-3773	range	_
21-12	3774-3775	:	_
21-13	3776-3778	16	_
21-14	3779-3781	to	_
21-15	3782-3784	25	_
21-16	3785-3790	years	_
21-17	3791-3792	)	_
21-18	3793-3794	,	_
21-19	3795-3797	66	_
21-20	3798-3799	%	_
21-21	3800-3804	were	_
21-22	3805-3811	female	_
21-23	3812-3813	,	_
21-24	3814-3817	and	_
21-25	3818-3819	,	_
21-26	3820-3822	on	_
21-27	3823-3824	a	_
21-28	3825-3830	scale	_
21-29	3831-3835	from	_
21-30	3836-3837	1	_
21-31	3838-3839	(	_
21-32	3840-3843	Not	_
21-33	3844-3848	very	_
21-34	3849-3853	well	_
21-35	3854-3855	)	_
21-36	3856-3858	to	_
21-37	3859-3860	3	_
21-38	3861-3862	(	_
21-39	3863-3867	Very	_
21-40	3868-3872	well	_
21-41	3873-3874	)	_
21-42	3875-3876	,	_
21-43	3877-3885	reported	_
21-44	3886-3893	knowing	_
21-45	3894-3897	the	_
21-46	3898-3910	participants	_
21-47	3911-3915	very	_
21-48	3916-3920	well	_
21-49	3921-3922	(	_
21-50	3923-3929	M=2.82	_
21-51	3930-3931	,	_
21-52	3932-3938	SD=0.4	_
21-53	3939-3940	)	_
21-54	3941-3942	.	_

Text=Analyses leveraged personality reports from 1–2 peers for each participant (M=1.30) as relatively few participants had all 3 reports completed by friends (5%).
22-1	3943-3951	Analyses	_
22-2	3952-3961	leveraged	_
22-3	3962-3973	personality	_
22-4	3974-3981	reports	_
22-5	3982-3986	from	_
22-6	3987-3990	1–2	_
22-7	3991-3996	peers	_
22-8	3997-4000	for	_
22-9	4001-4005	each	_
22-10	4006-4017	participant	_
22-11	4018-4019	(	_
22-12	4020-4026	M=1.30	_
22-13	4027-4028	)	_
22-14	4029-4031	as	_
22-15	4032-4042	relatively	_
22-16	4043-4046	few	_
22-17	4047-4059	participants	_
22-18	4060-4063	had	_
22-19	4064-4067	all	_
22-20	4068-4069	3	_
22-21	4070-4077	reports	_
22-22	4078-4087	completed	_
22-23	4088-4090	by	_
22-24	4091-4098	friends	_
22-25	4099-4100	(	_
22-26	4101-4102	5	_
22-27	4103-4104	%	_
22-28	4105-4106	)	_
22-29	4107-4108	.	_

Text=Of the 418 participants with peer-report data, 377 had imaging data meeting quality control criteria (see fMRI methods below).
23-1	4109-4111	Of	_
23-2	4112-4115	the	_
23-3	4116-4119	418	_
23-4	4120-4132	participants	_
23-5	4133-4137	with	_
23-6	4138-4149	peer-report	_
23-7	4150-4154	data	_
23-8	4155-4156	,	_
23-9	4157-4160	377	_
23-10	4161-4164	had	_
23-11	4165-4172	imaging	_
23-12	4173-4177	data	_
23-13	4178-4185	meeting	_
23-14	4186-4193	quality	_
23-15	4194-4201	control	_
23-16	4202-4210	criteria	_
23-17	4211-4212	(	_
23-18	4213-4216	see	_
23-19	4217-4221	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
23-20	4222-4229	methods	_
23-21	4230-4235	below	_
23-22	4236-4237	)	_
23-23	4238-4239	.	_

Text=Participant characteristics for this final sample are reported in Table 1.
24-1	4240-4251	Participant	_
24-2	4252-4267	characteristics	_
24-3	4268-4271	for	_
24-4	4272-4276	this	_
24-5	4277-4282	final	_
24-6	4283-4289	sample	_
24-7	4290-4293	are	_
24-8	4294-4302	reported	_
24-9	4303-4305	in	_
24-10	4306-4311	Table	_
24-11	4312-4313	1	_
24-12	4314-4315	.	_

Text=2.2 Functional Neuroimaging Participants were scanned using a research-dedicated GE MR750 3T scanner at the Duke-UNC Brain Imaging and Analysis Center.
25-1	4316-4319	2.2	_
25-2	4320-4330	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
25-3	4331-4343	Neuroimaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
25-4	4344-4356	Participants	_
25-5	4357-4361	were	_
25-6	4362-4369	scanned	_
25-7	4370-4375	using	_
25-8	4376-4377	a	_
25-9	4378-4396	research-dedicated	_
25-10	4397-4399	GE	_
25-11	4400-4405	MR750	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
25-12	4406-4408	3T	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
25-13	4409-4416	scanner	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
25-14	4417-4419	at	_
25-15	4420-4423	the	_
25-16	4424-4432	Duke-UNC	_
25-17	4433-4438	Brain	_
25-18	4439-4446	Imaging	_
25-19	4447-4450	and	_
25-20	4451-4459	Analysis	_
25-21	4460-4466	Center	_
25-22	4467-4468	.	_

Text=Amygdala activity to threat was assessed using an emotional face matching paradigm described in detail in previous research.
26-1	4469-4477	Amygdala	_
26-2	4478-4486	activity	_
26-3	4487-4489	to	_
26-4	4490-4496	threat	_
26-5	4497-4500	was	_
26-6	4501-4509	assessed	_
26-7	4510-4515	using	_
26-8	4516-4518	an	_
26-9	4519-4528	emotional	_
26-10	4529-4533	face	_
26-11	4534-4542	matching	_
26-12	4543-4551	paradigm	_
26-13	4552-4561	described	_
26-14	4562-4564	in	_
26-15	4565-4571	detail	_
26-16	4572-4574	in	_
26-17	4575-4583	previous	_
26-18	4584-4592	research	_
26-19	4593-4594	.	_

Text=The paradigm version used in the DNS consisted of four blocks of a face-processing task (one block each for fearful, angry, surprised, and neutral faces; order counter-balanced across participants) interleaved with five blocks of a sensorimotor control task.
27-1	4595-4598	The	_
27-2	4599-4607	paradigm	_
27-3	4608-4615	version	_
27-4	4616-4620	used	_
27-5	4621-4623	in	_
27-6	4624-4627	the	_
27-7	4628-4631	DNS	http://maven.renci.org/NeuroBridge/neurobridge#Thing
27-8	4632-4641	consisted	_
27-9	4642-4644	of	_
27-10	4645-4649	four	_
27-11	4650-4656	blocks	_
27-12	4657-4659	of	_
27-13	4660-4661	a	_
27-14	4662-4677	face-processing	_
27-15	4678-4682	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
27-16	4683-4684	(	_
27-17	4685-4688	one	_
27-18	4689-4694	block	_
27-19	4695-4699	each	_
27-20	4700-4703	for	_
27-21	4704-4711	fearful	_
27-22	4712-4713	,	_
27-23	4714-4719	angry	_
27-24	4720-4721	,	_
27-25	4722-4731	surprised	_
27-26	4732-4733	,	_
27-27	4734-4737	and	_
27-28	4738-4745	neutral	_
27-29	4746-4751	faces	_
27-30	4752-4753	;	_
27-31	4754-4759	order	_
27-32	4760-4776	counter-balanced	_
27-33	4777-4783	across	_
27-34	4784-4796	participants	_
27-35	4797-4798	)	_
27-36	4799-4810	interleaved	_
27-37	4811-4815	with	_
27-38	4816-4820	five	_
27-39	4821-4827	blocks	_
27-40	4828-4830	of	_
27-41	4831-4832	a	_
27-42	4833-4845	sensorimotor	_
27-43	4846-4853	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
27-44	4854-4858	task	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
27-45	4859-4860	.	_

Text=Each trial in the face matching blocks lasted for 4 seconds with a variable interstimulus interval (ISI) of 2 to 6 seconds (M=4 seconds), for a total block length of 48 seconds.
28-1	4861-4865	Each	_
28-2	4866-4871	trial	_
28-3	4872-4874	in	_
28-4	4875-4878	the	_
28-5	4879-4883	face	_
28-6	4884-4892	matching	_
28-7	4893-4899	blocks	_
28-8	4900-4906	lasted	_
28-9	4907-4910	for	_
28-10	4911-4912	4	_
28-11	4913-4920	seconds	_
28-12	4921-4925	with	_
28-13	4926-4927	a	_
28-14	4928-4936	variable	_
28-15	4937-4950	interstimulus	_
28-16	4951-4959	interval	_
28-17	4960-4961	(	_
28-18	4962-4965	ISI	_
28-19	4966-4967	)	_
28-20	4968-4970	of	_
28-21	4971-4972	2	_
28-22	4973-4975	to	_
28-23	4976-4977	6	_
28-24	4978-4985	seconds	_
28-25	4986-4987	(	_
28-26	4988-4991	M=4	_
28-27	4992-4999	seconds	_
28-28	5000-5001	)	_
28-29	5002-5003	,	_
28-30	5004-5007	for	_
28-31	5008-5009	a	_
28-32	5010-5015	total	_
28-33	5016-5021	block	_
28-34	5022-5028	length	_
28-35	5029-5031	of	_
28-36	5032-5034	48	_
28-37	5035-5042	seconds	_
28-38	5043-5044	.	_

Text=In the shape matching control blocks, each of the six shape trios was presented for 4 seconds with a fixed ISI of 2 seconds for a total block length of 36 seconds.
29-1	5045-5047	In	_
29-2	5048-5051	the	_
29-3	5052-5057	shape	_
29-4	5058-5066	matching	_
29-5	5067-5074	control	_
29-6	5075-5081	blocks	_
29-7	5082-5083	,	_
29-8	5084-5088	each	_
29-9	5089-5091	of	_
29-10	5092-5095	the	_
29-11	5096-5099	six	_
29-12	5100-5105	shape	_
29-13	5106-5111	trios	_
29-14	5112-5115	was	_
29-15	5116-5125	presented	_
29-16	5126-5129	for	_
29-17	5130-5131	4	_
29-18	5132-5139	seconds	_
29-19	5140-5144	with	_
29-20	5145-5146	a	_
29-21	5147-5152	fixed	_
29-22	5153-5156	ISI	_
29-23	5157-5159	of	_
29-24	5160-5161	2	_
29-25	5162-5169	seconds	_
29-26	5170-5173	for	_
29-27	5174-5175	a	_
29-28	5176-5181	total	_
29-29	5182-5187	block	_
29-30	5188-5194	length	_
29-31	5195-5197	of	_
29-32	5198-5200	36	_
29-33	5201-5208	seconds	_
29-34	5209-5210	.	_

Text=Imaging data were processed with the standard DNS pre-processing stream.
30-1	5211-5218	Imaging	_
30-2	5219-5223	data	_
30-3	5224-5228	were	_
30-4	5229-5238	processed	_
30-5	5239-5243	with	_
30-6	5244-5247	the	_
30-7	5248-5256	standard	_
30-8	5257-5260	DNS	_
30-9	5261-5275	pre-processing	_
30-10	5276-5282	stream	_
30-11	5283-5284	.	_

Text=These procedures, as well as quality assurance procedures, have been described in detail in our prior published work and are available online (https: //www.haririlab.com/methods/amygdala.html).
31-1	5285-5290	These	_
31-2	5291-5301	procedures	_
31-3	5302-5303	,	_
31-4	5304-5306	as	_
31-5	5307-5311	well	_
31-6	5312-5314	as	_
31-7	5315-5322	quality	_
31-8	5323-5332	assurance	_
31-9	5333-5343	procedures	_
31-10	5344-5345	,	_
31-11	5346-5350	have	_
31-12	5351-5355	been	_
31-13	5356-5365	described	_
31-14	5366-5368	in	_
31-15	5369-5375	detail	_
31-16	5376-5378	in	_
31-17	5379-5382	our	_
31-18	5383-5388	prior	_
31-19	5389-5398	published	_
31-20	5399-5403	work	_
31-21	5404-5407	and	_
31-22	5408-5411	are	_
31-23	5412-5421	available	_
31-24	5422-5428	online	_
31-25	5429-5430	(	_
31-26	5431-5436	https	_
31-27	5437-5438	:	_
31-28	5439-5480	//www.haririlab.com/methods/amygdala.html	_
31-29	5481-5482	)	_
31-30	5483-5484	.	_

Text=Quality control criteria for inclusion of a participant ’ s imaging data were: <5% volumes exceed quality control criteria for motion or signal intensity outliers, ≥ 90% coverage of signal within the anatomically-defined bilateral amygdala region of interest, and accuracy ≥75% on the matching task performed during scanning.
32-1	5485-5492	Quality	_
32-2	5493-5500	control	_
32-3	5501-5509	criteria	_
32-4	5510-5513	for	_
32-5	5514-5523	inclusion	_
32-6	5524-5526	of	_
32-7	5527-5528	a	_
32-8	5529-5540	participant	_
32-9	5541-5542	’	_
32-10	5543-5544	s	_
32-11	5545-5552	imaging	_
32-12	5553-5557	data	_
32-13	5558-5562	were	_
32-14	5563-5564	:	_
32-15	5565-5566	<	_
32-16	5567-5568	5	_
32-17	5569-5570	%	_
32-18	5571-5578	volumes	_
32-19	5579-5585	exceed	_
32-20	5586-5593	quality	_
32-21	5594-5601	control	_
32-22	5602-5610	criteria	_
32-23	5611-5614	for	_
32-24	5615-5621	motion	_
32-25	5622-5624	or	_
32-26	5625-5631	signal	_
32-27	5632-5641	intensity	_
32-28	5642-5650	outliers	_
32-29	5651-5652	,	_
32-30	5653-5654	≥	_
32-31	5655-5657	90	_
32-32	5658-5659	%	_
32-33	5660-5668	coverage	_
32-34	5669-5671	of	_
32-35	5672-5678	signal	_
32-36	5679-5685	within	_
32-37	5686-5689	the	_
32-38	5690-5710	anatomically-defined	_
32-39	5711-5720	bilateral	_
32-40	5721-5729	amygdala	_
32-41	5730-5736	region	_
32-42	5737-5739	of	_
32-43	5740-5748	interest	_
32-44	5749-5750	,	_
32-45	5751-5754	and	_
32-46	5755-5763	accuracy	_
32-47	5764-5767	≥75	_
32-48	5768-5769	%	_
32-49	5770-5772	on	_
32-50	5773-5776	the	_
32-51	5777-5785	matching	_
32-52	5786-5790	task	_
32-53	5791-5800	performed	_
32-54	5801-5807	during	_
32-55	5808-5816	scanning	_
32-56	5817-5818	.	_

Text=Following pre-processing and the creation of contrast maps for the main effect of condition at the individual level, individual contrast images were then entered in second-level random effects models to determine mean condition-specific regional responses using one-sample t-tests.
33-1	5819-5828	Following	_
33-2	5829-5843	pre-processing	_
33-3	5844-5847	and	_
33-4	5848-5851	the	_
33-5	5852-5860	creation	_
33-6	5861-5863	of	_
33-7	5864-5872	contrast	_
33-8	5873-5877	maps	_
33-9	5878-5881	for	_
33-10	5882-5885	the	_
33-11	5886-5890	main	_
33-12	5891-5897	effect	_
33-13	5898-5900	of	_
33-14	5901-5910	condition	_
33-15	5911-5913	at	_
33-16	5914-5917	the	_
33-17	5918-5928	individual	_
33-18	5929-5934	level	_
33-19	5935-5936	,	_
33-20	5937-5947	individual	_
33-21	5948-5956	contrast	_
33-22	5957-5963	images	_
33-23	5964-5968	were	_
33-24	5969-5973	then	_
33-25	5974-5981	entered	_
33-26	5982-5984	in	_
33-27	5985-5997	second-level	_
33-28	5998-6004	random	_
33-29	6005-6012	effects	_
33-30	6013-6019	models	_
33-31	6020-6022	to	_
33-32	6023-6032	determine	_
33-33	6033-6037	mean	_
33-34	6038-6056	condition-specific	_
33-35	6057-6065	regional	_
33-36	6066-6075	responses	_
33-37	6076-6081	using	_
33-38	6082-6092	one-sample	_
33-39	6093-6100	t-tests	_
33-40	6101-6102	.	_

Text=We extracted parameter estimates from functional clusters activated within the centromedial and basolateral amygdala at p <.05 family-wise error (FWE) corrected across the search volumes, for the contrasts of the Angry block> Shape blocks and Fearful block> Shape blocks.
34-1	6103-6105	We	_
34-2	6106-6115	extracted	_
34-3	6116-6125	parameter	_
34-4	6126-6135	estimates	_
34-5	6136-6140	from	_
34-6	6141-6151	functional	_
34-7	6152-6160	clusters	_
34-8	6161-6170	activated	_
34-9	6171-6177	within	_
34-10	6178-6181	the	_
34-11	6182-6194	centromedial	_
34-12	6195-6198	and	_
34-13	6199-6210	basolateral	_
34-14	6211-6219	amygdala	_
34-15	6220-6222	at	_
34-16	6223-6224	p	_
34-17	6225-6226	<	_
34-18	6227-6230	.05	_
34-19	6231-6242	family-wise	_
34-20	6243-6248	error	_
34-21	6249-6250	(	_
34-22	6251-6254	FWE	_
34-23	6255-6256	)	_
34-24	6257-6266	corrected	_
34-25	6267-6273	across	_
34-26	6274-6277	the	_
34-27	6278-6284	search	_
34-28	6285-6292	volumes	_
34-29	6293-6294	,	_
34-30	6295-6298	for	_
34-31	6299-6302	the	_
34-32	6303-6312	contrasts	_
34-33	6313-6315	of	_
34-34	6316-6319	the	_
34-35	6320-6325	Angry	_
34-36	6326-6331	block	_
34-37	6332-6333	>	_
34-38	6334-6339	Shape	_
34-39	6340-6346	blocks	_
34-40	6347-6350	and	_
34-41	6351-6358	Fearful	_
34-42	6359-6364	block	_
34-43	6365-6366	>	_
34-44	6367-6372	Shape	_
34-45	6373-6379	blocks	_
34-46	6380-6381	.	_

Text=Amygdala regions were defined from probabilistic cytoarchitectonic mapping of the basolateral and centromedial amygdala sub-regions.
35-1	6382-6390	Amygdala	_
35-2	6391-6398	regions	_
35-3	6399-6403	were	_
35-4	6404-6411	defined	_
35-5	6412-6416	from	_
35-6	6417-6430	probabilistic	_
35-7	6431-6448	cytoarchitectonic	_
35-8	6449-6456	mapping	_
35-9	6457-6459	of	_
35-10	6460-6463	the	_
35-11	6464-6475	basolateral	_
35-12	6476-6479	and	_
35-13	6480-6492	centromedial	_
35-14	6493-6501	amygdala	_
35-15	6502-6513	sub-regions	_
35-16	6514-6515	.	_

Text=Because there were 4 amygdala sub-regions for each contrast (left and right basolateral and centromedial amygdala), we averaged these to obtain a mean measure of amygdala activity for each contrast of interest (Angry> Shapes and Fear> Shapes), similar to analytical approaches used in our prior research.
36-1	6516-6523	Because	_
36-2	6524-6529	there	_
36-3	6530-6534	were	_
36-4	6535-6536	4	_
36-5	6537-6545	amygdala	_
36-6	6546-6557	sub-regions	_
36-7	6558-6561	for	_
36-8	6562-6566	each	_
36-9	6567-6575	contrast	_
36-10	6576-6577	(	_
36-11	6578-6582	left	_
36-12	6583-6586	and	_
36-13	6587-6592	right	_
36-14	6593-6604	basolateral	_
36-15	6605-6608	and	_
36-16	6609-6621	centromedial	_
36-17	6622-6630	amygdala	_
36-18	6631-6632	)	_
36-19	6633-6634	,	_
36-20	6635-6637	we	_
36-21	6638-6646	averaged	_
36-22	6647-6652	these	_
36-23	6653-6655	to	_
36-24	6656-6662	obtain	_
36-25	6663-6664	a	_
36-26	6665-6669	mean	_
36-27	6670-6677	measure	_
36-28	6678-6680	of	_
36-29	6681-6689	amygdala	_
36-30	6690-6698	activity	_
36-31	6699-6702	for	_
36-32	6703-6707	each	_
36-33	6708-6716	contrast	_
36-34	6717-6719	of	_
36-35	6720-6728	interest	_
36-36	6729-6730	(	_
36-37	6731-6736	Angry	_
36-38	6737-6738	>	_
36-39	6739-6745	Shapes	_
36-40	6746-6749	and	_
36-41	6750-6754	Fear	_
36-42	6755-6756	>	_
36-43	6757-6763	Shapes	_
36-44	6764-6765	)	_
36-45	6766-6767	,	_
36-46	6768-6775	similar	_
36-47	6776-6778	to	_
36-48	6779-6789	analytical	_
36-49	6790-6800	approaches	_
36-50	6801-6805	used	_
36-51	6806-6808	in	_
36-52	6809-6812	our	_
36-53	6813-6818	prior	_
36-54	6819-6827	research	_
36-55	6828-6829	.	_

Text=To control for Type I error, we conducted all analyses first with the mean measures of amygdala activity and only examined effects for sub-regions when effects for the mean measures were significant.
37-1	6830-6832	To	_
37-2	6833-6840	control	_
37-3	6841-6844	for	_
37-4	6845-6849	Type	_
37-5	6850-6851	I	_
37-6	6852-6857	error	_
37-7	6858-6859	,	_
37-8	6860-6862	we	_
37-9	6863-6872	conducted	_
37-10	6873-6876	all	_
37-11	6877-6885	analyses	_
37-12	6886-6891	first	_
37-13	6892-6896	with	_
37-14	6897-6900	the	_
37-15	6901-6905	mean	_
37-16	6906-6914	measures	_
37-17	6915-6917	of	_
37-18	6918-6926	amygdala	_
37-19	6927-6935	activity	_
37-20	6936-6939	and	_
37-21	6940-6944	only	_
37-22	6945-6953	examined	_
37-23	6954-6961	effects	_
37-24	6962-6965	for	_
37-25	6966-6977	sub-regions	_
37-26	6978-6982	when	_
37-27	6983-6990	effects	_
37-28	6991-6994	for	_
37-29	6995-6998	the	_
37-30	6999-7003	mean	_
37-31	7004-7012	measures	_
37-32	7013-7017	were	_
37-33	7018-7029	significant	_
37-34	7030-7031	.	_

Text=2.3 Self- and peer-reported personality As part of the DNS protocol, all participants completed the NEO Personality Inventory Revised (NEO-PI-R).
38-1	7032-7035	2.3	_
38-2	7036-7041	Self-	_
38-3	7042-7045	and	_
38-4	7046-7059	peer-reported	_
38-5	7060-7071	personality	_
38-6	7072-7074	As	_
38-7	7075-7079	part	_
38-8	7080-7082	of	_
38-9	7083-7086	the	_
38-10	7087-7090	DNS	http://maven.renci.org/NeuroBridge/neurobridge#Thing
38-11	7091-7099	protocol	_
38-12	7100-7101	,	_
38-13	7102-7105	all	_
38-14	7106-7118	participants	_
38-15	7119-7128	completed	_
38-16	7129-7132	the	_
38-17	7133-7136	NEO	http://maven.renci.org/NeuroBridge/neurobridge#NEOPersonalityInventoryRevised
38-18	7137-7148	Personality	http://maven.renci.org/NeuroBridge/neurobridge#NEOPersonalityInventoryRevised
38-19	7149-7158	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#NEOPersonalityInventoryRevised
38-20	7159-7166	Revised	http://maven.renci.org/NeuroBridge/neurobridge#NEOPersonalityInventoryRevised
38-21	7167-7168	(	http://maven.renci.org/NeuroBridge/neurobridge#NEOPersonalityInventoryRevised
38-22	7169-7177	NEO-PI-R	http://maven.renci.org/NeuroBridge/neurobridge#NEOPersonalityInventoryRevised
38-23	7178-7179	)	_
38-24	7180-7181	.	_

Text=Total scores on the scales of extraversion, conscientiousness, neuroticism, agreeableness, and openness were used as measures of self-reported personality.
39-1	7182-7187	Total	_
39-2	7188-7194	scores	_
39-3	7195-7197	on	_
39-4	7198-7201	the	_
39-5	7202-7208	scales	_
39-6	7209-7211	of	_
39-7	7212-7224	extraversion	_
39-8	7225-7226	,	_
39-9	7227-7244	conscientiousness	_
39-10	7245-7246	,	_
39-11	7247-7258	neuroticism	_
39-12	7259-7260	,	_
39-13	7261-7274	agreeableness	_
39-14	7275-7276	,	_
39-15	7277-7280	and	_
39-16	7281-7289	openness	_
39-17	7290-7294	were	_
39-18	7295-7299	used	_
39-19	7300-7302	as	_
39-20	7303-7311	measures	_
39-21	7312-7314	of	_
39-22	7315-7328	self-reported	_
39-23	7329-7340	personality	_
39-24	7341-7342	.	_

Text=Skewness and kurtosis for all self-reported personality measures were <1, with the exception of conscientiousness, which had kurtosis=1.3.
40-1	7343-7351	Skewness	_
40-2	7352-7355	and	_
40-3	7356-7364	kurtosis	_
40-4	7365-7368	for	_
40-5	7369-7372	all	_
40-6	7373-7386	self-reported	_
40-7	7387-7398	personality	_
40-8	7399-7407	measures	_
40-9	7408-7412	were	_
40-10	7413-7414	<	_
40-11	7415-7416	1	_
40-12	7417-7418	,	_
40-13	7419-7423	with	_
40-14	7424-7427	the	_
40-15	7428-7437	exception	_
40-16	7438-7440	of	_
40-17	7441-7458	conscientiousness	_
40-18	7459-7460	,	_
40-19	7461-7466	which	_
40-20	7467-7470	had	_
40-21	7471-7483	kurtosis=1.3	_
40-22	7484-7485	.	_

Text=Informant reports were adapted from those used in the Dunedin Multidisciplinary Health and Development Study.
41-1	7486-7495	Informant	_
41-2	7496-7503	reports	_
41-3	7504-7508	were	_
41-4	7509-7516	adapted	_
41-5	7517-7521	from	_
41-6	7522-7527	those	_
41-7	7528-7532	used	_
41-8	7533-7535	in	_
41-9	7536-7539	the	_
41-10	7540-7547	Dunedin	_
41-11	7548-7565	Multidisciplinary	_
41-12	7566-7572	Health	_
41-13	7573-7576	and	_
41-14	7577-7588	Development	_
41-15	7589-7594	Study	_
41-16	7595-7596	.	_

Text=In the informant report of personality, there were five items for each of the five traits.
42-1	7597-7599	In	_
42-2	7600-7603	the	_
42-3	7604-7613	informant	_
42-4	7614-7620	report	_
42-5	7621-7623	of	_
42-6	7624-7635	personality	_
42-7	7636-7637	,	_
42-8	7638-7643	there	_
42-9	7644-7648	were	_
42-10	7649-7653	five	_
42-11	7654-7659	items	_
42-12	7660-7663	for	_
42-13	7664-7668	each	_
42-14	7669-7671	of	_
42-15	7672-7675	the	_
42-16	7676-7680	five	_
42-17	7681-7687	traits	_
42-18	7688-7689	.	_

Text=Informants were asked to rate the participant on each item (e.g., “ talks a lot ”) on a scale from 1 (“ No, doesn ’ t apply ”) to 3 (“ Yes, certainly applies ”).
43-1	7690-7700	Informants	_
43-2	7701-7705	were	_
43-3	7706-7711	asked	_
43-4	7712-7714	to	_
43-5	7715-7719	rate	_
43-6	7720-7723	the	_
43-7	7724-7735	participant	_
43-8	7736-7738	on	_
43-9	7739-7743	each	_
43-10	7744-7748	item	_
43-11	7749-7750	(	_
43-12	7751-7755	e.g.	_
43-13	7756-7757	,	_
43-14	7758-7759	“	_
43-15	7760-7765	talks	_
43-16	7766-7767	a	_
43-17	7768-7771	lot	_
43-18	7772-7773	”	_
43-19	7774-7775	)	_
43-20	7776-7778	on	_
43-21	7779-7780	a	_
43-22	7781-7786	scale	_
43-23	7787-7791	from	_
43-24	7792-7793	1	_
43-25	7794-7795	(	_
43-26	7796-7797	“	_
43-27	7798-7800	No	_
43-28	7801-7802	,	_
43-29	7803-7808	doesn	_
43-30	7809-7810	’	_
43-31	7811-7812	t	_
43-32	7813-7818	apply	_
43-33	7819-7820	”	_
43-34	7821-7822	)	_
43-35	7823-7825	to	_
43-36	7826-7827	3	_
43-37	7828-7829	(	_
43-38	7830-7831	“	_
43-39	7832-7835	Yes	_
43-40	7836-7837	,	_
43-41	7838-7847	certainly	_
43-42	7848-7855	applies	_
43-43	7856-7857	”	_
43-44	7858-7859	)	_
43-45	7860-7861	.	_

Text=Items for each trait were summed to obtain peer measures of extraversion, conscientiousness, neuroticism, agreeableness, and openness that could range from 5 to 15.
44-1	7862-7867	Items	_
44-2	7868-7871	for	_
44-3	7872-7876	each	_
44-4	7877-7882	trait	_
44-5	7883-7887	were	_
44-6	7888-7894	summed	_
44-7	7895-7897	to	_
44-8	7898-7904	obtain	_
44-9	7905-7909	peer	_
44-10	7910-7918	measures	_
44-11	7919-7921	of	_
44-12	7922-7934	extraversion	_
44-13	7935-7936	,	_
44-14	7937-7954	conscientiousness	_
44-15	7955-7956	,	_
44-16	7957-7968	neuroticism	_
44-17	7969-7970	,	_
44-18	7971-7984	agreeableness	_
44-19	7985-7986	,	_
44-20	7987-7990	and	_
44-21	7991-7999	openness	_
44-22	8000-8004	that	_
44-23	8005-8010	could	_
44-24	8011-8016	range	_
44-25	8017-8021	from	_
44-26	8022-8023	5	_
44-27	8024-8026	to	_
44-28	8027-8029	15	_
44-29	8030-8031	.	_

Text=When there were two peer informants, total scores on each personality trait were averaged across the two informants.
45-1	8032-8036	When	_
45-2	8037-8042	there	_
45-3	8043-8047	were	_
45-4	8048-8051	two	_
45-5	8052-8056	peer	_
45-6	8057-8067	informants	_
45-7	8068-8069	,	_
45-8	8070-8075	total	_
45-9	8076-8082	scores	_
45-10	8083-8085	on	_
45-11	8086-8090	each	_
45-12	8091-8102	personality	_
45-13	8103-8108	trait	_
45-14	8109-8113	were	_
45-15	8114-8122	averaged	_
45-16	8123-8129	across	_
45-17	8130-8133	the	_
45-18	8134-8137	two	_
45-19	8138-8148	informants	_
45-20	8149-8150	.	_

Text=Skewness and kurtosis for all peer-reported personality measures were <1.
46-1	8151-8159	Skewness	_
46-2	8160-8163	and	_
46-3	8164-8172	kurtosis	_
46-4	8173-8176	for	_
46-5	8177-8180	all	_
46-6	8181-8194	peer-reported	_
46-7	8195-8206	personality	_
46-8	8207-8215	measures	_
46-9	8216-8220	were	_
46-10	8221-8222	<	_
46-11	8223-8224	1	_
46-12	8225-8226	.	_

Text=We performed supplementary analyses to examine whether results differed for participants who were rated by one or two peer informants (see Supplement).
47-1	8227-8229	We	_
47-2	8230-8239	performed	_
47-3	8240-8253	supplementary	_
47-4	8254-8262	analyses	_
47-5	8263-8265	to	_
47-6	8266-8273	examine	_
47-7	8274-8281	whether	_
47-8	8282-8289	results	_
47-9	8290-8298	differed	_
47-10	8299-8302	for	_
47-11	8303-8315	participants	_
47-12	8316-8319	who	_
47-13	8320-8324	were	_
47-14	8325-8330	rated	_
47-15	8331-8333	by	_
47-16	8334-8337	one	_
47-17	8338-8340	or	_
47-18	8341-8344	two	_
47-19	8345-8349	peer	_
47-20	8350-8360	informants	_
47-21	8361-8362	(	_
47-22	8363-8366	see	_
47-23	8367-8377	Supplement	_
47-24	8378-8379	)	_
47-25	8380-8381	.	_

Text=Reliability, inter-rater agreement (for individuals who had two peer informants), and correlations between self- and peer-report are provided in the results.
48-1	8382-8393	Reliability	_
48-2	8394-8395	,	_
48-3	8396-8407	inter-rater	_
48-4	8408-8417	agreement	_
48-5	8418-8419	(	_
48-6	8420-8423	for	_
48-7	8424-8435	individuals	_
48-8	8436-8439	who	_
48-9	8440-8443	had	_
48-10	8444-8447	two	_
48-11	8448-8452	peer	_
48-12	8453-8463	informants	_
48-13	8464-8465	)	_
48-14	8466-8467	,	_
48-15	8468-8471	and	_
48-16	8472-8484	correlations	_
48-17	8485-8492	between	_
48-18	8493-8498	self-	_
48-19	8499-8502	and	_
48-20	8503-8514	peer-report	_
48-21	8515-8518	are	_
48-22	8519-8527	provided	_
48-23	8528-8530	in	_
48-24	8531-8534	the	_
48-25	8535-8542	results	_
48-26	8543-8544	.	_

Text=Intraclass correlation coefficients (ICCs) were estimated with a one-way random effects model; single measures and average measures ICCs are reported.
49-1	8545-8555	Intraclass	_
49-2	8556-8567	correlation	_
49-3	8568-8580	coefficients	_
49-4	8581-8582	(	_
49-5	8583-8587	ICCs	_
49-6	8588-8589	)	_
49-7	8590-8594	were	_
49-8	8595-8604	estimated	_
49-9	8605-8609	with	_
49-10	8610-8611	a	_
49-11	8612-8619	one-way	_
49-12	8620-8626	random	_
49-13	8627-8634	effects	_
49-14	8635-8640	model	_
49-15	8641-8642	;	_
49-16	8643-8649	single	_
49-17	8650-8658	measures	_
49-18	8659-8662	and	_
49-19	8663-8670	average	_
49-20	8671-8679	measures	_
49-21	8680-8684	ICCs	_
49-22	8685-8688	are	_
49-23	8689-8697	reported	_
49-24	8698-8699	.	_

Text=We also report correlations between personality measures and anxiety, as measured by the trait version of the State-Trait Anxiety Inventory.
50-1	8700-8702	We	_
50-2	8703-8707	also	_
50-3	8708-8714	report	_
50-4	8715-8727	correlations	_
50-5	8728-8735	between	_
50-6	8736-8747	personality	_
50-7	8748-8756	measures	_
50-8	8757-8760	and	_
50-9	8761-8768	anxiety	_
50-10	8769-8770	,	_
50-11	8771-8773	as	_
50-12	8774-8782	measured	_
50-13	8783-8785	by	_
50-14	8786-8789	the	_
50-15	8790-8795	trait	_
50-16	8796-8803	version	_
50-17	8804-8806	of	_
50-18	8807-8810	the	_
50-19	8811-8822	State-Trait	_
50-20	8823-8830	Anxiety	_
50-21	8831-8840	Inventory	_
50-22	8841-8842	.	_

Text=2.4 Problem drinking at baseline and follow-up Problem drinking was assessed at baseline and follow-up with the Alcohol Use Disorders Identification Test (AUDIT).
51-1	8843-8846	2.4	_
51-2	8847-8854	Problem	_
51-3	8855-8863	drinking	_
51-4	8864-8866	at	_
51-5	8867-8875	baseline	_
51-6	8876-8879	and	_
51-7	8880-8889	follow-up	_
51-8	8890-8897	Problem	_
51-9	8898-8906	drinking	_
51-10	8907-8910	was	_
51-11	8911-8919	assessed	_
51-12	8920-8922	at	_
51-13	8923-8931	baseline	_
51-14	8932-8935	and	_
51-15	8936-8945	follow-up	_
51-16	8946-8950	with	_
51-17	8951-8954	the	_
51-18	8955-8962	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-19	8963-8966	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-20	8967-8976	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-21	8977-8991	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-22	8992-8996	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-23	8997-8998	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-24	8999-9004	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-25	9005-9006	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
51-26	9007-9008	.	_

Text=The AUDIT consists of items assessing alcohol use that may be considered risky or hazardous.
52-1	9009-9012	The	_
52-2	9013-9018	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
52-3	9019-9027	consists	_
52-4	9028-9030	of	_
52-5	9031-9036	items	_
52-6	9037-9046	assessing	_
52-7	9047-9054	alcohol	_
52-8	9055-9058	use	_
52-9	9059-9063	that	_
52-10	9064-9067	may	_
52-11	9068-9070	be	_
52-12	9071-9081	considered	_
52-13	9082-9087	risky	_
52-14	9088-9090	or	_
52-15	9091-9100	hazardous	_
52-16	9101-9102	.	_

Text=It contains three subscales: hazardous alcohol use, dependence symptoms, and harmful alcohol use.
53-1	9103-9105	It	_
53-2	9106-9114	contains	_
53-3	9115-9120	three	_
53-4	9121-9130	subscales	_
53-5	9131-9132	:	_
53-6	9133-9142	hazardous	_
53-7	9143-9150	alcohol	_
53-8	9151-9154	use	_
53-9	9155-9156	,	_
53-10	9157-9167	dependence	_
53-11	9168-9176	symptoms	_
53-12	9177-9178	,	_
53-13	9179-9182	and	_
53-14	9183-9190	harmful	_
53-15	9191-9198	alcohol	_
53-16	9199-9202	use	_
53-17	9203-9204	.	_

Text=We first ran all analyses using total scores across the three subscales and performed post hoc analyses to examine specific subscales when results with the total score were significant.
54-1	9205-9207	We	_
54-2	9208-9213	first	_
54-3	9214-9217	ran	_
54-4	9218-9221	all	_
54-5	9222-9230	analyses	_
54-6	9231-9236	using	_
54-7	9237-9242	total	_
54-8	9243-9249	scores	_
54-9	9250-9256	across	_
54-10	9257-9260	the	_
54-11	9261-9266	three	_
54-12	9267-9276	subscales	_
54-13	9277-9280	and	_
54-14	9281-9290	performed	_
54-15	9291-9295	post	_
54-16	9296-9299	hoc	_
54-17	9300-9308	analyses	_
54-18	9309-9311	to	_
54-19	9312-9319	examine	_
54-20	9320-9328	specific	_
54-21	9329-9338	subscales	_
54-22	9339-9343	when	_
54-23	9344-9351	results	_
54-24	9352-9356	with	_
54-25	9357-9360	the	_
54-26	9361-9366	total	_
54-27	9367-9372	score	_
54-28	9373-9377	were	_
54-29	9378-9389	significant	_
54-30	9390-9391	.	_

Text=In addition to completing the AUDIT at baseline, participants were contacted by e-mail every 3 months after having completed their fMRI scan to fill out a follow-up questionnaire online (for further details see and).
55-1	9392-9394	In	_
55-2	9395-9403	addition	_
55-3	9404-9406	to	_
55-4	9407-9417	completing	_
55-5	9418-9421	the	_
55-6	9422-9427	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
55-7	9428-9430	at	_
55-8	9431-9439	baseline	_
55-9	9440-9441	,	_
55-10	9442-9454	participants	_
55-11	9455-9459	were	_
55-12	9460-9469	contacted	_
55-13	9470-9472	by	_
55-14	9473-9479	e-mail	_
55-15	9480-9485	every	_
55-16	9486-9487	3	_
55-17	9488-9494	months	_
55-18	9495-9500	after	_
55-19	9501-9507	having	_
55-20	9508-9517	completed	_
55-21	9518-9523	their	_
55-22	9524-9528	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
55-23	9529-9533	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
55-24	9534-9536	to	_
55-25	9537-9541	fill	_
55-26	9542-9545	out	_
55-27	9546-9547	a	_
55-28	9548-9557	follow-up	_
55-29	9558-9571	questionnaire	_
55-30	9572-9578	online	_
55-31	9579-9580	(	_
55-32	9581-9584	for	_
55-33	9585-9592	further	_
55-34	9593-9600	details	_
55-35	9601-9604	see	_
55-36	9605-9608	and	_
55-37	9609-9610	)	_
55-38	9611-9612	.	_

Text=Participants completed the AUDIT as part of this follow-up questionnaire; here they indicated how often they had exhibited problem drinking behavior since their last follow-up questionnaire.
56-1	9613-9625	Participants	_
56-2	9626-9635	completed	_
56-3	9636-9639	the	_
56-4	9640-9645	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
56-5	9646-9648	as	_
56-6	9649-9653	part	_
56-7	9654-9656	of	_
56-8	9657-9661	this	_
56-9	9662-9671	follow-up	_
56-10	9672-9685	questionnaire	_
56-11	9686-9687	;	_
56-12	9688-9692	here	_
56-13	9693-9697	they	_
56-14	9698-9707	indicated	_
56-15	9708-9711	how	_
56-16	9712-9717	often	_
56-17	9718-9722	they	_
56-18	9723-9726	had	_
56-19	9727-9736	exhibited	_
56-20	9737-9744	problem	_
56-21	9745-9753	drinking	_
56-22	9754-9762	behavior	_
56-23	9763-9768	since	_
56-24	9769-9774	their	_
56-25	9775-9779	last	_
56-26	9780-9789	follow-up	_
56-27	9790-9803	questionnaire	_
56-28	9804-9805	.	_

Text=Similar to our prior research, we used data from the most recent follow-up available for each participant.
57-1	9806-9813	Similar	_
57-2	9814-9816	to	_
57-3	9817-9820	our	_
57-4	9821-9826	prior	_
57-5	9827-9835	research	_
57-6	9836-9837	,	_
57-7	9838-9840	we	_
57-8	9841-9845	used	_
57-9	9846-9850	data	_
57-10	9851-9855	from	_
57-11	9856-9859	the	_
57-12	9860-9864	most	_
57-13	9865-9871	recent	_
57-14	9872-9881	follow-up	_
57-15	9882-9891	available	_
57-16	9892-9895	for	_
57-17	9896-9900	each	_
57-18	9901-9912	participant	_
57-19	9913-9914	.	_

Text=Of the current sample, 235 (56%) completed at least one follow-up and the most recent follow-up was completed on average over a year after the baseline assessment (M=530 days, SD=384, range=90 to 1706 days).
58-1	9915-9917	Of	_
58-2	9918-9921	the	_
58-3	9922-9929	current	_
58-4	9930-9936	sample	_
58-5	9937-9938	,	_
58-6	9939-9942	235	_
58-7	9943-9944	(	_
58-8	9945-9947	56	_
58-9	9948-9949	%	_
58-10	9950-9951	)	_
58-11	9952-9961	completed	_
58-12	9962-9964	at	_
58-13	9965-9970	least	_
58-14	9971-9974	one	_
58-15	9975-9984	follow-up	_
58-16	9985-9988	and	_
58-17	9989-9992	the	_
58-18	9993-9997	most	_
58-19	9998-10004	recent	_
58-20	10005-10014	follow-up	_
58-21	10015-10018	was	_
58-22	10019-10028	completed	_
58-23	10029-10031	on	_
58-24	10032-10039	average	_
58-25	10040-10044	over	_
58-26	10045-10046	a	_
58-27	10047-10051	year	_
58-28	10052-10057	after	_
58-29	10058-10061	the	_
58-30	10062-10070	baseline	_
58-31	10071-10081	assessment	_
58-32	10082-10083	(	_
58-33	10084-10089	M=530	_
58-34	10090-10094	days	_
58-35	10095-10096	,	_
58-36	10097-10103	SD=384	_
58-37	10104-10105	,	_
58-38	10106-10114	range=90	_
58-39	10115-10117	to	_
58-40	10118-10122	1706	_
58-41	10123-10127	days	_
58-42	10128-10129	)	_
58-43	10130-10131	.	_

Text=Participants who completed the follow-up were more likely to be younger at baseline, t (416) =2.74, p=.01, female, χ2 (1) =7.00, p=.01, higher in peer-reported conscientiousness, t (416) =−2.05, p=.04, lower in self-reported extraversion, t (416) =2.36, p=.02, higher in self-reported conscientiousness, t (416) = −2.38, p=.02, and have lower problem drinking behavior at baseline, t (416) =2.71, p=.01.
59-1	10132-10144	Participants	_
59-2	10145-10148	who	_
59-3	10149-10158	completed	_
59-4	10159-10162	the	_
59-5	10163-10172	follow-up	_
59-6	10173-10177	were	_
59-7	10178-10182	more	_
59-8	10183-10189	likely	_
59-9	10190-10192	to	_
59-10	10193-10195	be	_
59-11	10196-10203	younger	_
59-12	10204-10206	at	_
59-13	10207-10215	baseline	_
59-14	10216-10217	,	_
59-15	10218-10219	t	_
59-16	10220-10221	(	_
59-17	10222-10225	416	_
59-18	10226-10227	)	_
59-19	10228-10233	=2.74	_
59-20	10234-10235	,	_
59-21	10236-10241	p=.01	_
59-22	10242-10243	,	_
59-23	10244-10250	female	_
59-24	10251-10252	,	_
59-25	10253-10255	χ2	_
59-26	10256-10257	(	_
59-27	10258-10259	1	_
59-28	10260-10261	)	_
59-29	10262-10267	=7.00	_
59-30	10268-10269	,	_
59-31	10270-10275	p=.01	_
59-32	10276-10277	,	_
59-33	10278-10284	higher	_
59-34	10285-10287	in	_
59-35	10288-10301	peer-reported	_
59-36	10302-10319	conscientiousness	_
59-37	10320-10321	,	_
59-38	10322-10323	t	_
59-39	10324-10325	(	_
59-40	10326-10329	416	_
59-41	10330-10331	)	_
59-42	10332-10338	=−2.05	_
59-43	10339-10340	,	_
59-44	10341-10346	p=.04	_
59-45	10347-10348	,	_
59-46	10349-10354	lower	_
59-47	10355-10357	in	_
59-48	10358-10371	self-reported	_
59-49	10372-10384	extraversion	_
59-50	10385-10386	,	_
59-51	10387-10388	t	_
59-52	10389-10390	(	_
59-53	10391-10394	416	_
59-54	10395-10396	)	_
59-55	10397-10402	=2.36	_
59-56	10403-10404	,	_
59-57	10405-10410	p=.02	_
59-58	10411-10412	,	_
59-59	10413-10419	higher	_
59-60	10420-10422	in	_
59-61	10423-10436	self-reported	_
59-62	10437-10454	conscientiousness	_
59-63	10455-10456	,	_
59-64	10457-10458	t	_
59-65	10459-10460	(	_
59-66	10461-10464	416	_
59-67	10465-10466	)	_
59-68	10467-10468	=	_
59-69	10469-10474	−2.38	_
59-70	10475-10476	,	_
59-71	10477-10482	p=.02	_
59-72	10483-10484	,	_
59-73	10485-10488	and	_
59-74	10489-10493	have	_
59-75	10494-10499	lower	_
59-76	10500-10507	problem	_
59-77	10508-10516	drinking	_
59-78	10517-10525	behavior	_
59-79	10526-10528	at	_
59-80	10529-10537	baseline	_
59-81	10538-10539	,	_
59-82	10540-10541	t	_
59-83	10542-10543	(	_
59-84	10544-10547	416	_
59-85	10548-10549	)	_
59-86	10550-10555	=2.71	_
59-87	10556-10557	,	_
59-88	10558-10563	p=.01	_
59-89	10564-10565	.	_

Text=2.5 Statistical analysis All analyses were conducted with Mplus v7 software using full information maximum likelihood estimation with 1,000 bootstrapped samples to account for non-normality in the data.
60-1	10566-10569	2.5	_
60-2	10570-10581	Statistical	_
60-3	10582-10590	analysis	_
60-4	10591-10594	All	_
60-5	10595-10603	analyses	_
60-6	10604-10608	were	_
60-7	10609-10618	conducted	_
60-8	10619-10623	with	_
60-9	10624-10629	Mplus	_
60-10	10630-10632	v7	_
60-11	10633-10641	software	_
60-12	10642-10647	using	_
60-13	10648-10652	full	_
60-14	10653-10664	information	_
60-15	10665-10672	maximum	_
60-16	10673-10683	likelihood	_
60-17	10684-10694	estimation	_
60-18	10695-10699	with	_
60-19	10700-10705	1,000	_
60-20	10706-10718	bootstrapped	_
60-21	10719-10726	samples	_
60-22	10727-10729	to	_
60-23	10730-10737	account	_
60-24	10738-10741	for	_
60-25	10742-10755	non-normality	_
60-26	10756-10758	in	_
60-27	10759-10762	the	_
60-28	10763-10767	data	_
60-29	10768-10769	.	_

Text=Analyses proceeded in the following order: 1) testing the association between threat-related amygdala activity and self-reported personality; 2) testing the association between threat-related amygdala activity and peer-reported personality; 3) testing the association between threat-related amygdala activity and peer-reported personality, controlling for self-reported personality; 4) testing the association between peer-reported personality and future problem drinking behavior, controlling for self-reported personality and baseline problem drinking behavior; and 5) constructing an indirect effects model to assess the indirect effect of threat-related amygdala activity on future problem drinking via peer-reported personality.
61-1	10770-10778	Analyses	_
61-2	10779-10788	proceeded	_
61-3	10789-10791	in	_
61-4	10792-10795	the	_
61-5	10796-10805	following	_
61-6	10806-10811	order	_
61-7	10812-10813	:	_
61-8	10814-10815	1	_
61-9	10816-10817	)	_
61-10	10818-10825	testing	_
61-11	10826-10829	the	_
61-12	10830-10841	association	_
61-13	10842-10849	between	_
61-14	10850-10864	threat-related	_
61-15	10865-10873	amygdala	_
61-16	10874-10882	activity	_
61-17	10883-10886	and	_
61-18	10887-10900	self-reported	_
61-19	10901-10912	personality	_
61-20	10913-10914	;	_
61-21	10915-10916	2	_
61-22	10917-10918	)	_
61-23	10919-10926	testing	_
61-24	10927-10930	the	_
61-25	10931-10942	association	_
61-26	10943-10950	between	_
61-27	10951-10965	threat-related	_
61-28	10966-10974	amygdala	_
61-29	10975-10983	activity	_
61-30	10984-10987	and	_
61-31	10988-11001	peer-reported	_
61-32	11002-11013	personality	_
61-33	11014-11015	;	_
61-34	11016-11017	3	_
61-35	11018-11019	)	_
61-36	11020-11027	testing	_
61-37	11028-11031	the	_
61-38	11032-11043	association	_
61-39	11044-11051	between	_
61-40	11052-11066	threat-related	_
61-41	11067-11075	amygdala	_
61-42	11076-11084	activity	_
61-43	11085-11088	and	_
61-44	11089-11102	peer-reported	_
61-45	11103-11114	personality	_
61-46	11115-11116	,	_
61-47	11117-11128	controlling	_
61-48	11129-11132	for	_
61-49	11133-11146	self-reported	_
61-50	11147-11158	personality	_
61-51	11159-11160	;	_
61-52	11161-11162	4	_
61-53	11163-11164	)	_
61-54	11165-11172	testing	_
61-55	11173-11176	the	_
61-56	11177-11188	association	_
61-57	11189-11196	between	_
61-58	11197-11210	peer-reported	_
61-59	11211-11222	personality	_
61-60	11223-11226	and	_
61-61	11227-11233	future	_
61-62	11234-11241	problem	_
61-63	11242-11250	drinking	_
61-64	11251-11259	behavior	_
61-65	11260-11261	,	_
61-66	11262-11273	controlling	_
61-67	11274-11277	for	_
61-68	11278-11291	self-reported	_
61-69	11292-11303	personality	_
61-70	11304-11307	and	_
61-71	11308-11316	baseline	_
61-72	11317-11324	problem	_
61-73	11325-11333	drinking	_
61-74	11334-11342	behavior	_
61-75	11343-11344	;	_
61-76	11345-11348	and	_
61-77	11349-11350	5	_
61-78	11351-11352	)	_
61-79	11353-11365	constructing	_
61-80	11366-11368	an	_
61-81	11369-11377	indirect	_
61-82	11378-11385	effects	_
61-83	11386-11391	model	_
61-84	11392-11394	to	_
61-85	11395-11401	assess	_
61-86	11402-11405	the	_
61-87	11406-11414	indirect	_
61-88	11415-11421	effect	_
61-89	11422-11424	of	_
61-90	11425-11439	threat-related	_
61-91	11440-11448	amygdala	_
61-92	11449-11457	activity	_
61-93	11458-11460	on	_
61-94	11461-11467	future	_
61-95	11468-11475	problem	_
61-96	11476-11484	drinking	_
61-97	11485-11488	via	_
61-98	11489-11502	peer-reported	_
61-99	11503-11514	personality	_
61-100	11515-11516	.	_

Text=In addition, for all significant effects, we re-ran analyses winsorizing outliers for all continuous variables to +/− 3 SD from the mean.
62-1	11517-11519	In	_
62-2	11520-11528	addition	_
62-3	11529-11530	,	_
62-4	11531-11534	for	_
62-5	11535-11538	all	_
62-6	11539-11550	significant	_
62-7	11551-11558	effects	_
62-8	11559-11560	,	_
62-9	11561-11563	we	_
62-10	11564-11570	re-ran	_
62-11	11571-11579	analyses	_
62-12	11580-11591	winsorizing	_
62-13	11592-11600	outliers	_
62-14	11601-11604	for	_
62-15	11605-11608	all	_
62-16	11609-11619	continuous	_
62-17	11620-11629	variables	_
62-18	11630-11632	to	_
62-19	11633-11636	+/−	_
62-20	11637-11638	3	_
62-21	11639-11641	SD	_
62-22	11642-11646	from	_
62-23	11647-11650	the	_
62-24	11651-11655	mean	_
62-25	11656-11657	.	_

Text=In the first set of analyses, associations were examined between threat-related amygdala activity and self-reported personality.
63-1	11658-11660	In	_
63-2	11661-11664	the	_
63-3	11665-11670	first	_
63-4	11671-11674	set	_
63-5	11675-11677	of	_
63-6	11678-11686	analyses	_
63-7	11687-11688	,	_
63-8	11689-11701	associations	_
63-9	11702-11706	were	_
63-10	11707-11715	examined	_
63-11	11716-11723	between	_
63-12	11724-11738	threat-related	_
63-13	11739-11747	amygdala	_
63-14	11748-11756	activity	_
63-15	11757-11760	and	_
63-16	11761-11774	self-reported	_
63-17	11775-11786	personality	_
63-18	11787-11788	.	_

Text=For these analyses, mean amygdala activity to fearful facial expressions and mean amygdala activity to angry facial expressions were mean-centered and entered as predictors.
64-1	11789-11792	For	_
64-2	11793-11798	these	_
64-3	11799-11807	analyses	_
64-4	11808-11809	,	_
64-5	11810-11814	mean	_
64-6	11815-11823	amygdala	_
64-7	11824-11832	activity	_
64-8	11833-11835	to	_
64-9	11836-11843	fearful	_
64-10	11844-11850	facial	_
64-11	11851-11862	expressions	_
64-12	11863-11866	and	_
64-13	11867-11871	mean	_
64-14	11872-11880	amygdala	_
64-15	11881-11889	activity	_
64-16	11890-11892	to	_
64-17	11893-11898	angry	_
64-18	11899-11905	facial	_
64-19	11906-11917	expressions	_
64-20	11918-11922	were	_
64-21	11923-11936	mean-centered	_
64-22	11937-11940	and	_
64-23	11941-11948	entered	_
64-24	11949-11951	as	_
64-25	11952-11962	predictors	_
64-26	11963-11964	.	_

Text=Sex (0=male 1=female) was entered as a covariate, as well as presence of a psychiatric diagnosis (0=no psychiatric diagnosis 1=past or present psychiatric diagnosis), and baseline AUDIT total scores (mean centered).
65-1	11965-11968	Sex	_
65-2	11969-11970	(	_
65-3	11971-11977	0=male	_
65-4	11978-11986	1=female	_
65-5	11987-11988	)	_
65-6	11989-11992	was	_
65-7	11993-12000	entered	_
65-8	12001-12003	as	_
65-9	12004-12005	a	_
65-10	12006-12015	covariate	_
65-11	12016-12017	,	_
65-12	12018-12020	as	_
65-13	12021-12025	well	_
65-14	12026-12028	as	_
65-15	12029-12037	presence	_
65-16	12038-12040	of	_
65-17	12041-12042	a	_
65-18	12043-12054	psychiatric	_
65-19	12055-12064	diagnosis	_
65-20	12065-12066	(	_
65-21	12067-12071	0=no	_
65-22	12072-12083	psychiatric	_
65-23	12084-12093	diagnosis	_
65-24	12094-12100	1=past	_
65-25	12101-12103	or	_
65-26	12104-12111	present	_
65-27	12112-12123	psychiatric	_
65-28	12124-12133	diagnosis	_
65-29	12134-12135	)	_
65-30	12136-12137	,	_
65-31	12138-12141	and	_
65-32	12142-12150	baseline	_
65-33	12151-12156	AUDIT	_
65-34	12157-12162	total	_
65-35	12163-12169	scores	_
65-36	12170-12171	(	_
65-37	12172-12176	mean	_
65-38	12177-12185	centered	_
65-39	12186-12187	)	_
65-40	12188-12189	.	_

Text=The five self-reported personality traits were modeled as the outcome variables in five separate regressions.
66-1	12190-12193	The	_
66-2	12194-12198	five	_
66-3	12199-12212	self-reported	_
66-4	12213-12224	personality	_
66-5	12225-12231	traits	_
66-6	12232-12236	were	_
66-7	12237-12244	modeled	_
66-8	12245-12247	as	_
66-9	12248-12251	the	_
66-10	12252-12259	outcome	_
66-11	12260-12269	variables	_
66-12	12270-12272	in	_
66-13	12273-12277	five	_
66-14	12278-12286	separate	_
66-15	12287-12298	regressions	_
66-16	12299-12300	.	_

Text=We tested whether the association between amygdala activity and each personality trait differed for amygdala activity to fearful faces compared to angry faces.
67-1	12301-12303	We	_
67-2	12304-12310	tested	_
67-3	12311-12318	whether	_
67-4	12319-12322	the	_
67-5	12323-12334	association	_
67-6	12335-12342	between	_
67-7	12343-12351	amygdala	_
67-8	12352-12360	activity	_
67-9	12361-12364	and	_
67-10	12365-12369	each	_
67-11	12370-12381	personality	_
67-12	12382-12387	trait	_
67-13	12388-12396	differed	_
67-14	12397-12400	for	_
67-15	12401-12409	amygdala	_
67-16	12410-12418	activity	_
67-17	12419-12421	to	_
67-18	12422-12429	fearful	_
67-19	12430-12435	faces	_
67-20	12436-12444	compared	_
67-21	12445-12447	to	_
67-22	12448-12453	angry	_
67-23	12454-12459	faces	_
67-24	12460-12461	.	_

Text=To do so, we used a nested model comparison approach in Mplus.
68-1	12462-12464	To	_
68-2	12465-12467	do	_
68-3	12468-12470	so	_
68-4	12471-12472	,	_
68-5	12473-12475	we	_
68-6	12476-12480	used	_
68-7	12481-12482	a	_
68-8	12483-12489	nested	_
68-9	12490-12495	model	_
68-10	12496-12506	comparison	_
68-11	12507-12515	approach	_
68-12	12516-12518	in	_
68-13	12519-12524	Mplus	_
68-14	12525-12526	.	_

Text=Specifically, we first constructed a model in which the associations between amygdala activity and the personality trait were freed to vary for fearful and angry faces; we next constructed a nested model in which the association between amygdala activity to angry faces and a personality trait was constrained to be equal to the association between amygdala activity to fearful faces and a personality trait.
69-1	12527-12539	Specifically	_
69-2	12540-12541	,	_
69-3	12542-12544	we	_
69-4	12545-12550	first	_
69-5	12551-12562	constructed	_
69-6	12563-12564	a	_
69-7	12565-12570	model	_
69-8	12571-12573	in	_
69-9	12574-12579	which	_
69-10	12580-12583	the	_
69-11	12584-12596	associations	_
69-12	12597-12604	between	_
69-13	12605-12613	amygdala	_
69-14	12614-12622	activity	_
69-15	12623-12626	and	_
69-16	12627-12630	the	_
69-17	12631-12642	personality	_
69-18	12643-12648	trait	_
69-19	12649-12653	were	_
69-20	12654-12659	freed	_
69-21	12660-12662	to	_
69-22	12663-12667	vary	_
69-23	12668-12671	for	_
69-24	12672-12679	fearful	_
69-25	12680-12683	and	_
69-26	12684-12689	angry	_
69-27	12690-12695	faces	_
69-28	12696-12697	;	_
69-29	12698-12700	we	_
69-30	12701-12705	next	_
69-31	12706-12717	constructed	_
69-32	12718-12719	a	_
69-33	12720-12726	nested	_
69-34	12727-12732	model	_
69-35	12733-12735	in	_
69-36	12736-12741	which	_
69-37	12742-12745	the	_
69-38	12746-12757	association	_
69-39	12758-12765	between	_
69-40	12766-12774	amygdala	_
69-41	12775-12783	activity	_
69-42	12784-12786	to	_
69-43	12787-12792	angry	_
69-44	12793-12798	faces	_
69-45	12799-12802	and	_
69-46	12803-12804	a	_
69-47	12805-12816	personality	_
69-48	12817-12822	trait	_
69-49	12823-12826	was	_
69-50	12827-12838	constrained	_
69-51	12839-12841	to	_
69-52	12842-12844	be	_
69-53	12845-12850	equal	_
69-54	12851-12853	to	_
69-55	12854-12857	the	_
69-56	12858-12869	association	_
69-57	12870-12877	between	_
69-58	12878-12886	amygdala	_
69-59	12887-12895	activity	_
69-60	12896-12898	to	_
69-61	12899-12906	fearful	_
69-62	12907-12912	faces	_
69-63	12913-12916	and	_
69-64	12917-12918	a	_
69-65	12919-12930	personality	_
69-66	12931-12936	trait	_
69-67	12937-12938	.	_

Text=When constraining effects to be equal results in a significant reduction in model fit, this indicates the effects significantly differ by emotional stimulus type.
70-1	12939-12943	When	_
70-2	12944-12956	constraining	_
70-3	12957-12964	effects	_
70-4	12965-12967	to	_
70-5	12968-12970	be	_
70-6	12971-12976	equal	_
70-7	12977-12984	results	_
70-8	12985-12987	in	_
70-9	12988-12989	a	_
70-10	12990-13001	significant	_
70-11	13002-13011	reduction	_
70-12	13012-13014	in	_
70-13	13015-13020	model	_
70-14	13021-13024	fit	_
70-15	13025-13026	,	_
70-16	13027-13031	this	_
70-17	13032-13041	indicates	_
70-18	13042-13045	the	_
70-19	13046-13053	effects	_
70-20	13054-13067	significantly	_
70-21	13068-13074	differ	_
70-22	13075-13077	by	_
70-23	13078-13087	emotional	_
70-24	13088-13096	stimulus	_
70-25	13097-13101	type	_
70-26	13102-13103	.	_

Text=Because we performed five of these comparisons (for each of the 5 personality traits), we performed a false-discovery rate (FDR) correction to control for multiple comparisons.
71-1	13104-13111	Because	_
71-2	13112-13114	we	_
71-3	13115-13124	performed	_
71-4	13125-13129	five	_
71-5	13130-13132	of	_
71-6	13133-13138	these	_
71-7	13139-13150	comparisons	_
71-8	13151-13152	(	_
71-9	13153-13156	for	_
71-10	13157-13161	each	_
71-11	13162-13164	of	_
71-12	13165-13168	the	_
71-13	13169-13170	5	_
71-14	13171-13182	personality	_
71-15	13183-13189	traits	_
71-16	13190-13191	)	_
71-17	13192-13193	,	_
71-18	13194-13196	we	_
71-19	13197-13206	performed	_
71-20	13207-13208	a	_
71-21	13209-13224	false-discovery	_
71-22	13225-13229	rate	_
71-23	13230-13231	(	_
71-24	13232-13235	FDR	_
71-25	13236-13237	)	_
71-26	13238-13248	correction	_
71-27	13249-13251	to	_
71-28	13252-13259	control	_
71-29	13260-13263	for	_
71-30	13264-13272	multiple	_
71-31	13273-13284	comparisons	_
71-32	13285-13286	.	_

Text=Moderation by sex was tested through a similar approach using multi-group modeling to test whether parameter estimates significantly differed by sex.
72-1	13287-13297	Moderation	_
72-2	13298-13300	by	_
72-3	13301-13304	sex	_
72-4	13305-13308	was	_
72-5	13309-13315	tested	_
72-6	13316-13323	through	_
72-7	13324-13325	a	_
72-8	13326-13333	similar	_
72-9	13334-13342	approach	_
72-10	13343-13348	using	_
72-11	13349-13360	multi-group	_
72-12	13361-13369	modeling	_
72-13	13370-13372	to	_
72-14	13373-13377	test	_
72-15	13378-13385	whether	_
72-16	13386-13395	parameter	_
72-17	13396-13405	estimates	_
72-18	13406-13419	significantly	_
72-19	13420-13428	differed	_
72-20	13429-13431	by	_
72-21	13432-13435	sex	_
72-22	13436-13437	.	_

Text=A similar approach was used to model effects of amygdala activity on peer-reported personality traits.
73-1	13438-13439	A	_
73-2	13440-13447	similar	_
73-3	13448-13456	approach	_
73-4	13457-13460	was	_
73-5	13461-13465	used	_
73-6	13466-13468	to	_
73-7	13469-13474	model	_
73-8	13475-13482	effects	_
73-9	13483-13485	of	_
73-10	13486-13494	amygdala	_
73-11	13495-13503	activity	_
73-12	13504-13506	on	_
73-13	13507-13520	peer-reported	_
73-14	13521-13532	personality	_
73-15	13533-13539	traits	_
73-16	13540-13541	.	_

Text=In addition, when significant associations between mean amygdala activity and peer-reported personality were detected, follow-up analyses were conducted to determine whether they were specific to one hemisphere or amygdala sub-region through a similar parameter constraint approach.
74-1	13542-13544	In	_
74-2	13545-13553	addition	_
74-3	13554-13555	,	_
74-4	13556-13560	when	_
74-5	13561-13572	significant	_
74-6	13573-13585	associations	_
74-7	13586-13593	between	_
74-8	13594-13598	mean	_
74-9	13599-13607	amygdala	_
74-10	13608-13616	activity	_
74-11	13617-13620	and	_
74-12	13621-13634	peer-reported	_
74-13	13635-13646	personality	_
74-14	13647-13651	were	_
74-15	13652-13660	detected	_
74-16	13661-13662	,	_
74-17	13663-13672	follow-up	_
74-18	13673-13681	analyses	_
74-19	13682-13686	were	_
74-20	13687-13696	conducted	_
74-21	13697-13699	to	_
74-22	13700-13709	determine	_
74-23	13710-13717	whether	_
74-24	13718-13722	they	_
74-25	13723-13727	were	_
74-26	13728-13736	specific	_
74-27	13737-13739	to	_
74-28	13740-13743	one	_
74-29	13744-13754	hemisphere	_
74-30	13755-13757	or	_
74-31	13758-13766	amygdala	_
74-32	13767-13777	sub-region	_
74-33	13778-13785	through	_
74-34	13786-13787	a	_
74-35	13788-13795	similar	_
74-36	13796-13805	parameter	_
74-37	13806-13816	constraint	_
74-38	13817-13825	approach	_
74-39	13826-13827	.	_

Text=Next, to test whether associations with personality were unique to peer-report, we tested whether effects held while controlling for self-reported personality traits, as measured by the NEO-PI-R. Exploratory analyses were also conducted to examine whole-brain associations between peer-reported personality traits controlling for self-reported personality (see Supplement for whole-brain methods and results).
75-1	13828-13832	Next	_
75-2	13833-13834	,	_
75-3	13835-13837	to	_
75-4	13838-13842	test	_
75-5	13843-13850	whether	_
75-6	13851-13863	associations	_
75-7	13864-13868	with	_
75-8	13869-13880	personality	_
75-9	13881-13885	were	_
75-10	13886-13892	unique	_
75-11	13893-13895	to	_
75-12	13896-13907	peer-report	_
75-13	13908-13909	,	_
75-14	13910-13912	we	_
75-15	13913-13919	tested	_
75-16	13920-13927	whether	_
75-17	13928-13935	effects	_
75-18	13936-13940	held	_
75-19	13941-13946	while	_
75-20	13947-13958	controlling	_
75-21	13959-13962	for	_
75-22	13963-13976	self-reported	_
75-23	13977-13988	personality	_
75-24	13989-13995	traits	_
75-25	13996-13997	,	_
75-26	13998-14000	as	_
75-27	14001-14009	measured	_
75-28	14010-14012	by	_
75-29	14013-14016	the	_
75-30	14017-14026	NEO-PI-R.	_
75-31	14027-14038	Exploratory	_
75-32	14039-14047	analyses	_
75-33	14048-14052	were	_
75-34	14053-14057	also	_
75-35	14058-14067	conducted	_
75-36	14068-14070	to	_
75-37	14071-14078	examine	_
75-38	14079-14090	whole-brain	_
75-39	14091-14103	associations	_
75-40	14104-14111	between	_
75-41	14112-14125	peer-reported	_
75-42	14126-14137	personality	_
75-43	14138-14144	traits	_
75-44	14145-14156	controlling	_
75-45	14157-14160	for	_
75-46	14161-14174	self-reported	_
75-47	14175-14186	personality	_
75-48	14187-14188	(	_
75-49	14189-14192	see	_
75-50	14193-14203	Supplement	_
75-51	14204-14207	for	_
75-52	14208-14219	whole-brain	_
75-53	14220-14227	methods	_
75-54	14228-14231	and	_
75-55	14232-14239	results	_
75-56	14240-14241	)	_
75-57	14242-14243	.	_

Text=After having established that amygdala activity was associated with peer-reported conscientiousness and extraversion, we entered these traits as predictors of future problem drinking behavior controlling for baseline problem-drinking behavior, as well as self-reported conscientiousness and extraversion.
76-1	14244-14249	After	_
76-2	14250-14256	having	_
76-3	14257-14268	established	_
76-4	14269-14273	that	_
76-5	14274-14282	amygdala	_
76-6	14283-14291	activity	_
76-7	14292-14295	was	_
76-8	14296-14306	associated	_
76-9	14307-14311	with	_
76-10	14312-14325	peer-reported	_
76-11	14326-14343	conscientiousness	_
76-12	14344-14347	and	_
76-13	14348-14360	extraversion	_
76-14	14361-14362	,	_
76-15	14363-14365	we	_
76-16	14366-14373	entered	_
76-17	14374-14379	these	_
76-18	14380-14386	traits	_
76-19	14387-14389	as	_
76-20	14390-14400	predictors	_
76-21	14401-14403	of	_
76-22	14404-14410	future	_
76-23	14411-14418	problem	_
76-24	14419-14427	drinking	_
76-25	14428-14436	behavior	_
76-26	14437-14448	controlling	_
76-27	14449-14452	for	_
76-28	14453-14461	baseline	_
76-29	14462-14478	problem-drinking	_
76-30	14479-14487	behavior	_
76-31	14488-14489	,	_
76-32	14490-14492	as	_
76-33	14493-14497	well	_
76-34	14498-14500	as	_
76-35	14501-14514	self-reported	_
76-36	14515-14532	conscientiousness	_
76-37	14533-14536	and	_
76-38	14537-14549	extraversion	_
76-39	14550-14551	.	_

Text=The following were also entered as covariates in these analyses: psychiatric diagnosis, age at baseline, amygdala activity, time since scanning, and time since the last follow-up assessment.
77-1	14552-14555	The	_
77-2	14556-14565	following	_
77-3	14566-14570	were	_
77-4	14571-14575	also	_
77-5	14576-14583	entered	_
77-6	14584-14586	as	_
77-7	14587-14597	covariates	_
77-8	14598-14600	in	_
77-9	14601-14606	these	_
77-10	14607-14615	analyses	_
77-11	14616-14617	:	_
77-12	14618-14629	psychiatric	_
77-13	14630-14639	diagnosis	_
77-14	14640-14641	,	_
77-15	14642-14645	age	_
77-16	14646-14648	at	_
77-17	14649-14657	baseline	_
77-18	14658-14659	,	_
77-19	14660-14668	amygdala	_
77-20	14669-14677	activity	_
77-21	14678-14679	,	_
77-22	14680-14684	time	_
77-23	14685-14690	since	_
77-24	14691-14699	scanning	_
77-25	14700-14701	,	_
77-26	14702-14705	and	_
77-27	14706-14710	time	_
77-28	14711-14716	since	_
77-29	14717-14720	the	_
77-30	14721-14725	last	_
77-31	14726-14735	follow-up	_
77-32	14736-14746	assessment	_
77-33	14747-14748	.	_

Text=Similar to the procedures described above, we used multi-group models to examine moderation of these effects by sex.
78-1	14749-14756	Similar	_
78-2	14757-14759	to	_
78-3	14760-14763	the	_
78-4	14764-14774	procedures	_
78-5	14775-14784	described	_
78-6	14785-14790	above	_
78-7	14791-14792	,	_
78-8	14793-14795	we	_
78-9	14796-14800	used	_
78-10	14801-14812	multi-group	_
78-11	14813-14819	models	_
78-12	14820-14822	to	_
78-13	14823-14830	examine	_
78-14	14831-14841	moderation	_
78-15	14842-14844	of	_
78-16	14845-14850	these	_
78-17	14851-14858	effects	_
78-18	14859-14861	by	_
78-19	14862-14865	sex	_
78-20	14866-14867	.	_

Text=Finally, we constructed an indirect effects model to test the indirect effect of threat-related amygdala activity on future problem drinking via peer-reported personality.
79-1	14868-14875	Finally	_
79-2	14876-14877	,	_
79-3	14878-14880	we	_
79-4	14881-14892	constructed	_
79-5	14893-14895	an	_
79-6	14896-14904	indirect	_
79-7	14905-14912	effects	_
79-8	14913-14918	model	_
79-9	14919-14921	to	_
79-10	14922-14926	test	_
79-11	14927-14930	the	_
79-12	14931-14939	indirect	_
79-13	14940-14946	effect	_
79-14	14947-14949	of	_
79-15	14950-14964	threat-related	_
79-16	14965-14973	amygdala	_
79-17	14974-14982	activity	_
79-18	14983-14985	on	_
79-19	14986-14992	future	_
79-20	14993-15000	problem	_
79-21	15001-15009	drinking	_
79-22	15010-15013	via	_
79-23	15014-15027	peer-reported	_
79-24	15028-15039	personality	_
79-25	15040-15041	.	_

Text=The indirect effect was assessed by estimating bias-corrected 95% confidence intervals using 1,000 bootstrapped samples; confidence intervals that do not include 0 are considered to be significant at p <.05.
80-1	15042-15045	The	_
80-2	15046-15054	indirect	_
80-3	15055-15061	effect	_
80-4	15062-15065	was	_
80-5	15066-15074	assessed	_
80-6	15075-15077	by	_
80-7	15078-15088	estimating	_
80-8	15089-15103	bias-corrected	_
80-9	15104-15106	95	_
80-10	15107-15108	%	_
80-11	15109-15119	confidence	_
80-12	15120-15129	intervals	_
80-13	15130-15135	using	_
80-14	15136-15141	1,000	_
80-15	15142-15154	bootstrapped	_
80-16	15155-15162	samples	_
80-17	15163-15164	;	_
80-18	15165-15175	confidence	_
80-19	15176-15185	intervals	_
80-20	15186-15190	that	_
80-21	15191-15193	do	_
80-22	15194-15197	not	_
80-23	15198-15205	include	_
80-24	15206-15207	0	_
80-25	15208-15211	are	_
80-26	15212-15222	considered	_
80-27	15223-15225	to	_
80-28	15226-15228	be	_
80-29	15229-15240	significant	_
80-30	15241-15243	at	_
80-31	15244-15245	p	_
80-32	15246-15247	<	_
80-33	15248-15251	.05	_
80-34	15252-15253	.	_

Text=We report results for the indirect effect using self-reported personality for comparison.
81-1	15254-15256	We	_
81-2	15257-15263	report	_
81-3	15264-15271	results	_
81-4	15272-15275	for	_
81-5	15276-15279	the	_
81-6	15280-15288	indirect	_
81-7	15289-15295	effect	_
81-8	15296-15301	using	_
81-9	15302-15315	self-reported	_
81-10	15316-15327	personality	_
81-11	15328-15331	for	_
81-12	15332-15342	comparison	_
81-13	15343-15344	.	_

